A multicenter-retrospective study of non-small-cell lung carcinoma harboring uncommon epidermal growth factor receptor (EGFR) mutations: different subtypes of EGFR exon 19 deletion-insertions exhibit the clinical characteristics and prognosis of non-small cell lung carcinoma.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
Bmc Cancer
Keppens, Cleo C; Dequeker, Elisabeth M C EMC; Rouleau, Etienne E; 't Hart, Nils N; Bubendorf, Lukas L; Dufraing, Kelly K; Garrec, Céline C; Guéguen, Paul P; Lamy, Aude A; Marchetti, Antonio A; Pauwels, Patrick P; Ryska, Ales A; Tack, Véronique V; Tornillo, Luigi L; Van Casteren, Kaat K; von der Thüsen, Jan H JH; Zwaenepoel, Karen K; Lissenberg-Witte, Birgit B; Thunnissen, Erik E; Schuuring, Ed E
Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.
Bmc Cancer
Tan, Wan-Ling WL; Ng, Quan Sing QS; Lim, Cindy C; Tan, Eng Huat EH; Toh, Chee Keong CK; Ang, Mei-Kim MK; Kanesvaran, Ravindran R; Jain, Amit A; Tan, Daniel S W DSW; Lim, Darren Wan-Teck DW